fbpx
 

Hypothyroidism

 

Hypothyroidism is a chronic pathological condition of the endocrine system, that affects the thyroid gland. In Hypothyroidism, the thyroid gland does not produce enough of certain significant hormones (T4 and T3). Patients suffering from hypothyroidism need to take daily a synthetic form of the hormones that the thyroid gland is under-producing.

 

Diagnosis of Real Causes & Treatment of Hypothyroidism

  • Gradual restoration of cellular function
  • Personalized therapeutic protocols, without chemical residues and excipients
  • Treating the real causes
  • Therapeutic formulas that work alone or in combination with any other medication
  • Adopting a Molecular / Therapeutic Nutrition Plan

 

Symptoms of Hypothyroidism

In the early stages of the disease, symptoms may not be noticeable. The symptoms that usually lead a physician to test for Hypothyroidism, include dizziness, skin dryness, weight gain, constipation, fatigue, irregular period, palpitations, goiter,  impaired memory, muscle weakness, muscle/joint pain,  increased sensitivity to cold or hoarse voice.

 

Since the symptoms are highly variable and non-specific, the only way for someone to find out whether hypothyroidism is present, is through a TSH blood test.

Pathophysiology of Hypothyroidism

The thyroid gland is a small gland located on the front part of the neck. It is responsible for the provision of energy to nearly every organ of the human body. Under normal circumstances the thyroid gland predominantly produces thyroxine (T4) which is then converted to triiodothyronine (T3). These processes require iodine and tyrosine and are controlled by the thyroid stimulating hormone (TSH). TSH is secreted by the pituitary gland.

 

There are different types of hypothyroidism. Primary hypothyroidism, where peripheral thyroid disorders lead to a reduction of T3 and T4 production and a compensatory increase of TSH levels. In secondary hypothyroidism, both TSH and T3/T4 levels are decreased. In tertiary hypothyroidism, disorders in the hypothalamus lead to decreased levels of TSH and T3/T4.

 

There is also subclinical hypothyroidism where the levels of TSH can be mildly increased and the levels of T3 and T4 are normal.

 

Epidemiology of Hypothyroidism and Risk factors

Large population studies have shown that 0.3-0.4% of the population may suffer from over hypothyroidism. The percentage for subclinical hypothyroidism increases to 4.3-8.5%.

 

Hypothyroidism is more common among women aged over 60 years old, but it can begin at any age. The thyroid gland dysfunction can be clinically evident or subclinical (early and mild form of the disease).

 

Hypothyroidism can coexist along with autoimmune diseases such as Rheumatoid arthritis, lupus and type 1 Diabetes and most commonly with Hashimoto thyroiditis (production of auto-antibodies against the thyroid gland).

 

Other risk factors include a positive thyroid disease family history, treatment with radioactive iodine, partial thyroidectomy and exposure to irradiation (neck and upper chest areas).

 

hypothyroidism treatment

 

Hypothyroidism – Treatment

 

Hypothyroidism – Treatment

The general view concerning thyroid disorders is that there is no effective treatment available just effective management. That is not true.

The usual treatment of Hypothyroidism aims to provide the body with the missing hormones that can be no longer produced by the thyroid gland. That’s achieved through prescription of synthetic thyroid hormones, typically substitutions of T4 hormone that regulate the levels of TSH and it’s the only treatment available the last decades. In day to day clinical practice it is evident that the patient is often de-regulated every now and then. A constant change in drug dosages is required in order to manage the symptoms.

This can impact the patients’ psychology as they feel that the disease can never be treated effectively while concerns arise about the effects the often dysregulation may have on their health in the long run.

 

Uncovering the true causes of Hypothyroidism

The proposed therapeutic protocols are based on specific medical algorithms that utilize the diagnostic tests’ results. Depending on the laboratory tests findings, the thorough medical history, the symptoms and the presence of other underlying or concomitant diseases the therapeutic treatment schemes are individually defined.

Hypothyroidism is treated through elimination and balance of the underlying biochemical, molecular and hormonal causes.

This can be achieved through treatment protocols that aim to restore the micro nutrient deficiencies and inadequacies, re- adjust the neurotransmitters, remove heavy metals and to enrich nutrition with anti-inflammatory agents.

The personalized therapeutic protocols need to be implemented for a period of six to eighteen months, depending on the clinical status of the patient. After the treatment period, patients who keep following the additional instructions and guidelines provided reduce significantly the chances of a disease relapse.

Treatment protocols can be safely combined with any other medication the patient is currently prescribed.

The suitable therapeutic approach is the one that brings about the greater benefit for the patient, based on both clinical and laboratory values improvement.
 
 

Dr. Nikoleta Koini, M.D.

Doctor of Functional, Preventive, Anti-ageing and Restorative Medicine.

Diplomate and Board Certified in Anti-aging, Preventive, Functional and Regenerative Medicine from A4M (American Academy in Antiaging Medicine).

Functional Corporation
Partners

 

Read more:


Subclinical Hypothyroidism

 

References


  • Nobuyuki Amino 4 Autoimmunity and hypothyroidism Bailiére’s Clinical Endocrinology and Metabolism Volume 2, Issue 3 August 1988. doi:10.1016/S0950-351X(88)80055-7
  • van Rijn LE, Pop VJ, Williams GR. Low bone mineral density is related to high physiological levels of free thyroxine in peri-menopausal women. Eur J Endocrinol. 2014;170(3):461‐468. Published 2014 Feb 7. doi:10.1530/EJE-13-0769
  • Yaylali O, Kirac S, Yilmaz M, et al. Does hypothyroidism affect gastrointestinal motility?. Gastroenterol Res Pract. 2009;2009:529802. doi:10.1155/2009/529802
  • NHS “Erectile dysfunction (impotence)” 16 August 2017
  • Kalra S, Unnikrishnan AG, Sahay R. The hypoglycemic side of hypothyroidism. Indian J Endocrinol Metab. 2014;18(1):1‐3. doi:10.4103/2230-8210.126517
  • Abrams JJ, Grundy SM. Cholesterol metabolism in hypothyroidism and hyperthyroidism in man. J Lipid Res. 1981;22(2):323‐338.
  • CJ Gardner, P Richardson, et al. Hypothyroidism in a patient with non-alcoholic fatty liver disease BMJ 2011; 342
  • Sintzel F, Mallaret M, Bougerol T. Potentialisation par les hormones thyroïdiennes des traitements tricycliques et sérotoninergiques dans les dépressions résistantes [Potentializing of tricyclics and serotoninergics by thyroid hormones in resistant depressive disorders]. Encephale. 2004;30(3):267‐275. doi:10.1016/s0013-7006(04)95439-5
  • Berent D, Zboralski K, Orzechowska A, Gałecki P. Thyroid hormones associated with depression severity and clinical outcome in patients with major depressive disorder. Mol Biol Rep. 2014;41(4):2419‐2425. doi:10.1007/s11033-014-3097-6
  • Brănişteanu DE, Dimitriu A, Vieriu M, et al. Cutaneous manifestations associated with thyroid disease. Rev Med Chir Soc Med Nat Iasi. 2014;118(4):953‐958.
  • B. Winsa, MD, A. Karlsson, MD et al. Stressful life events and Graves’ disease The Lancet VOLUME 338, ISSUE 8781, P1475-1479, DECEMBER 14, 1991
  • Matos‐Santos, A., Nobre, E.L., Costa, J.G.E., Nogueira, P.J., Macedo, A., Galvão‐Teles, A. and De Castro, J.J. (2001), Relationship between the number and impact of stressful life events and the onset of Graves’ disease and toxic nodular goitre. Clinical Endocrinology, 55: 15-19. doi:10.1046/j.1365-2265.2001.01332.x
  • Sategna-Guidetti C, Bruno M, Mazza E, et al. Autoimmune thyroid diseases and coeliac disease. Eur J Gastroenterol Hepatol. 1998;10(11):927‐931. doi:10.1097/00042737-199811000-00005
  • Mainardi E, Montanelli A, Dotti M, Nano R, Moscato G. Thyroid-related autoantibodies and celiac disease: a role for a gluten-free diet?. J Clin Gastroenterol. 2002;35(3):245‐248. doi:10.1097/00004836-200209000-00009
  • Roland Gärtner, Barbara C. H. Gasnier, Johannes W. Dietrich, Bjarne Krebs, Matthias W. A. Angstwurm, Selenium Supplementation in Patients with Autoimmune Thyroiditis Decreases Thyroid Peroxidase Antibodies Concentrations, The Journal of Clinical Endocrinology & Metabolism, Volume 87, Issue 4, 1 April 2002, Pages 1687–1691
  • Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C. Vitamin D: modulator of the immune system. Curr Opin Pharmacol. 2010;10(4):482‐496. doi:10.1016/j.coph.2010.04.001
  • Arrieta MC, Bistritz L, Meddings JB. Alterations in intestinal permeability. Gut. 2006;55(10):1512‐1520. doi:10.1136/gut.2005.085373
  • Langer P, Kocan A, Tajtaková M, et al. Fish from industrially polluted freshwater as the main source of organochlorinated pollutants and increased frequency of thyroid disorders and dysglycemia. Chemosphere. 2007;67(9):S379‐S385. doi:10.1016/j.chemosphere.2006.05.132
  • Martin I. Surks, M.D., and Rubens Sievert, M.D. Drugs and Thyroid Function N Engl J Med 1995; 333:1688-1694 DOI: 10.1056/NEJM199512213332507
  • Boukis MA, Koutras DA, Souvatzoglou A, Evangelopoulou A, Vrontakis M, Moulopoulos SD. Thyroid hormone and immunological studies in endemic goiter. J Clin Endocrinol Metab. 1983;57(4):859‐862. doi:10.1210/jcem-57-4-859
  • Tomer Y, Huber A. The etiology of autoimmune thyroid disease: a story of genes and environment. J Autoimmun. 2009;32(3-4):231‐239. doi:10.1016/j.jaut.2009.02.007
  • Vestergaard P, Rejnmark L, Weeke J, et al. Smoking as a risk factor for Graves’ disease, toxic nodular goiter, and autoimmune hypothyroidism. Thyroid. 2002;12(1):69‐75. doi:10.1089/105072502753451995
  • Wajner SM, Goemann IM, Bueno AL, Larsen PR, Maia AL. IL-6 promotes nonthyroidal illness syndrome by blocking thyroxine activation while promoting thyroid hormone inactivation in human cells. J Clin Invest. 2011;121(5):1834‐1845. doi:10.1172/JCI44678
  • Farhangi MA, Keshavarz SA, Eshraghian M, Ostadrahimi A, Saboor-Yaraghi AA. The effect of vitamin A supplementation on thyroid function in premenopausal women. J Am Coll Nutr. 2012;31(4):268‐274. doi:10.1080/07315724.2012.10720431
  • Hedrén E, Diaz V, Svanberg U. Estimation of carotenoid accessibility from carrots determined by an in vitro digestion method. Eur J Clin Nutr. 2002;56(5):425‐430. doi:10.1038/sj.ejcn.1601329
  • Olivieri O, Girelli D, Stanzial AM, Rossi L, Bassi A, Corrocher R. Selenium, zinc, and thyroid hormones in healthy subjects: low T3/T4 ratio in the elderly is related to impaired selenium status. Biol Trace Elem Res. 1996;51(1):31‐41. doi:10.1007/BF02790145
  • Drutel A, Archambeaud F, Caron P. Selenium and the thyroid gland: more good news for clinicians. Clin Endocrinol (Oxf). 2013;78(2):155‐164. doi:10.1111/cen.12066
  • Zimmermann MB, Köhrle J. The impact of iron and selenium deficiencies on iodine and thyroid metabolism: biochemistry and relevance to public health. Thyroid. 2002;12(10):867‐878. doi:10.1089/105072502761016494
  • Jain RB. Thyroid function and serum copper, selenium, and zinc in general U.S. population. Biol Trace Elem Res. 2014;159(1-3):87‐98. doi:10.1007/s12011-014-9992-9
  • Understanding Local Control of Thyroid Hormones: (Deiodinases Function and Activity) NAHIS
  • Nobuyuki Amino 4 Autoimmunity and hypothyroidism Baillière’s Clinical Endocrinology and Metabolism Volume 2, Issue 3, August 1988, Pages 591-617
  • Yang, J., Yang, X. & Li, M. Baicalin, a natural compound, promotes regulatory T cell differentiation. BMC Complement Altern Med 12, 64 (2012).
  • Asvold BO, Bjøro T, Nilsen TI, Gunnell D, Vatten LJ. Thyrotropin levels and risk of fatal coronary heart disease: the HUNT study. Arch Intern Med. 2008;168(8):855‐860. doi:10.1001/archinte.168.8.855
  • Anthony Martin Gerdes and Giorgio Iervasi Thyroid Replacement Therapy and Heart Failure Circulation 2010;122:385–393
  • Hiroaki Kimura and Patrizio Caturegli Chemokine Orchestration of Autoimmune Thyroiditis Thyroid 2007 17:10, 1005-1011
  • Kjellman BF, Ljunggren JG, Beck-Friis J, Wetterberg L. Reverse T3 levels in affective disorders. Psychiatry Res. 1983;10(1):1‐9. doi:10.1016/0165-1781(83)90022-7
  • Mebis L, van den Berghe G. The hypothalamus-pituitary-thyroid axis in critical illness. Neth J Med. 2009;67(10):332‐340.
  • Rannem T, Ladefoged K, Hylander E, Hegnhøj J, Staun M. Selenium depletion in patients with gastrointestinal diseases: are there any predictive factors?. Scand J Gastroenterol. 1998;33(10):1057‐1061. doi:10.1080/003655298750026750
  • Vitamin B12 Health Sheet NIH March 30, 2020
  • Schroeder AC, Privalsky ML. Thyroid hormones, t3 and t4, in the brain. Front Endocrinol (Lausanne). 2014;5:40. Published 2014 Mar 31. doi:10.3389/fendo.2014.00040
  • Moncayo R, Kroiss A, Oberwinkler M, et al. The role of selenium, vitamin C, and zinc in benign thyroid diseases and of selenium in malignant thyroid diseases: Low selenium levels are found in subacute and silent thyroiditis and in papillary and follicular carcinoma. BMC Endocr Disord. 2008;8:2. Published 2008 Jan 25. doi:10.1186/1472-6823-8-2
  • Guy E. Abraham, M.D. (1)and David Brownstein, M.D. Evidence that the administration of Vitamin C improves a defective cellular transport mechanism for iodine: A Case Report Optimox
  • Anna J Duffield, Christine D Thomson, Kristina E Hill, Sheila Williams, An estimation of selenium requirements for New Zealanders, The American Journal of Clinical Nutrition, Volume 70, Issue 5, November 1999, Pages 896–903
  • Hossein-nezhad A, Spira A, Holick MF. Influence of vitamin D status and vitamin D3 supplementation on genome wide expression of white blood cells: a randomized double-blind clinical trial. PLoS One. 2013;8(3):e58725. doi:10.1371/journal.pone.0058725